|
This is an index of adverse event reports related to Aromasin (Exemestane). Click on the relevant link below to view a selection of reports according to the event's seriousness level and/or the nature of the adverse reaction. Or scroll down to view a sample of recent reports further on this page.
Our database includes reports from Jan 2007 to Dec 2007. The information is not vetted and should not be cosidered as verified clinical evidence.
All cases (109)
Cases resulting in a serious event (108)
Cases resulting in death (1)
Cases resulting in life threatening events (5)
Cases resulting in hospitalization (33)
Cases resulting in disability (6)
Cases resulting in other serious reactions (75)
Below is a sample of adverse event reports reports related to Aromasin (Exemestane). For a complete list and/or a specific selection of reports, please use the links in the index above.
Adverse event in female receiving Aromasin (Exemestane)
Reported by a consumer/non-health professional from United States on 2007-10-31
Patient: female, weighing 50.0 kg (110.0 pounds)
Adverse reactions / side effects: Hot Flush, Arthralgia, Osteoporosis, Insomnia, Drug Interaction, Depression, Trigger Finger
Suspect drug(s):
Aromasin (Exemestane)
Other drugs received by patient possibly interacting with the suspect drug:
Zoloft
Indication: Depression
Other drugs received by patient: Ativan; Wygesic
Adverse event in female receiving Aromasin (Exemestane)
Reported by a physician from Italy on 2007-10-26
Patient: female
Adverse reactions / side effects: Renal Cell Carcinoma Stage Unspecified
Adverse event resulted in: hospitalization
Suspect drug(s):
Aromasin (Exemestane)
Other drugs received by patient: Prinzide; Pantorc; Zyloric ^faes^
Adverse event in female receiving Aromasin (Exemestane)
Reported by a physician from Germany on 2007-10-23
Patient: female, weighing 57.0 kg (125.4 pounds)
Adverse reactions / side effects: Hepatic Failure, Rash
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Aromasin
Administration route: Oral
Indication: Breast Cancer Metastatic
Katadolon
Indication: Bone Pain
Other drugs received by patient: Pamidronate Disodium; Zometa; Arimidex
Adverse event in female receiving Aromasin (Exemestane)
Reported by a physician from Germany on 2007-10-19
Patient: female
Adverse reactions / side effects: Skin Ulcer, Peripheral Vascular Disorder, Stasis Dermatitis
Suspect drug(s):
Aromasin (Exemestane)
Other drugs received by patient: Hydrochlorothiazide; Molsidomine; Ramipril; Moxonidine; Metohexal
Adverse event in 75 year old female receiving Aromasin (Exemestane)
Reported by a health professional (non-physician/pharmacist) from France on 2007-10-12
Patient: 75 year old female
Adverse reactions / side effects: Osteonecrosis
Suspect drug(s):
Aromasin
Administration route: Oral
Indication: Breast Cancer Metastatic
Cortancyl
Dosage: daily dose:15mg-freq:frequency: daily
Administration route: Oral
Indication: Rheumatoid Arthritis
Kredex
Administration route: Oral
Levothyrox
Administration route: Oral
Indication: Hypothyroidism
Lyrica
Administration route: Oral
Indication: Neuropathy
Perindopril Erbumine
Administration route: Oral
Indication: Hypertension
Plavix
Administration route: Oral
Indication: Arteritis
Zometa
Indication: Breast Cancer Metastatic
Start date: 2005-09-01
End date: 2007-06-30
Other drugs received by patient: Calcidose; Diffu K; Tardyferon
Adverse event in female receiving Aromasin (Exemestane)
Reported by a health professional (non-physician/pharmacist) from France on 2007-10-12
Patient: female
Adverse reactions / side effects: Periarthritis
Adverse event resulted in: hospitalization
Suspect drug(s):
Aromasin (Exemestane)
Adverse event in female receiving Aromasin (Exemestane)
Reported by a health professional (non-physician/pharmacist) from Germany on 2007-10-09
Patient: female
Adverse reactions / side effects: Thrombocytopenia
Adverse event resulted in: disablity
Suspect drug(s):
Aromasin (Exemestane)
Adverse event in 47 year old female receiving Aromasin (Exemestane)
Reported by a physician from Germany on 2007-10-08
Patient: 47 year old female
Adverse reactions / side effects: Uterine Haemorrhage
Suspect drug(s):
Aromasin (Exemestane)
Adverse event in female receiving Aromasin (Exemestane)
Reported by a physician from Germany on 2007-10-05
Patient: female, weighing 57.0 kg (125.4 pounds)
Adverse reactions / side effects: Hepatic Failure, Rash
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Aromasin
Administration route: Oral
Indication: Breast Cancer Metastatic
Katadolon
Indication: Bone Pain
Other drugs received by patient: Pamidronate Disodium; Zometa; Arimidex
Adverse event in 59 year old female receiving Aromasin (Exemestane)
Reported by a physician from Japan on 2007-10-02
Patient: 59 year old female
Adverse reactions / side effects: Hepatic Function Abnormal
Suspect drug(s):
Aromasin
Administration route: Oral
Indication: Breast Cancer
Start date: 2007-04-23
End date: 2007-07-09
Lorazepam
Dosage: daily dose:2mg-freq:cyclic : cyclic
Administration route: Oral
Indication: Anxiety
Start date: 2006-12-01
End date: 2007-07-09
Adverse event in 63 year old female receiving Aromasin (Exemestane)
Reported by a physician from Germany on 2007-10-02
Patient: 63 year old female
Adverse reactions / side effects: Blood Alkaline Phosphatase Increased, Gamma-Glutamyltransferase Increased, Transaminases Increased
Suspect drug(s):
Aromasin (Exemestane)
Adverse event in female receiving Aromasin (Exemestane)
Reported by a physician from Japan on 2007-10-01
Patient: female
Adverse reactions / side effects: Interstitial Lung Disease
Suspect drug(s):
Aromasin (Exemestane)
Adverse event in female receiving Aromasin (Exemestane)
Reported by a physician from Germany on 2007-10-01
Patient: female
Adverse reactions / side effects: Skin Ulcer
Adverse event resulted in: disablity
Suspect drug(s):
Aromasin (Exemestane)
Adverse event in 53 year old female receiving Aromasin (Exemestane)
Reported by a individual with unspecified qualification from United States on 2007-10-01
Patient: 53 year old female, weighing 48.6 kg (106.9 pounds)
Adverse reactions / side effects: Rheumatoid Arthritis, Arthropathy, Arthralgia, Drug Interaction
Adverse event resulted in: disablity
Suspect drug(s):
Arimidex
Administration route: Oral
Indication: Breast Cancer
Start date: 2006-09-01
End date: 2007-04-01
Aromasin
Methotrexate
Other drugs received by patient: Celebrex; Xanax; Celexa
Adverse event in 72 year old female receiving Aromasin (Exemestane)
Reported by a pharmacist from Japan on 2007-10-01
Patient: 72 year old female
Adverse reactions / side effects: Somnolence, Hypertension
Suspect drug(s):
Aromasin (Exemestane)
Other drugs received by patient: Perdipine-LA
Adverse event in female receiving Aromasin (Exemestane)
Reported by a consumer/non-health professional from United States on 2007-07-31
Patient: female, weighing 79.4 kg (174.7 pounds)
Adverse reactions / side effects: Confusional State, Lung Infection, Fall, Hepatic Enzyme Increased, Hepatic Steatosis, Myalgia, Syncope, Fatigue, Sleep Disorder, Neoplasm Malignant, Tooth Discolouration, Abdominal Distension, Gait Disturbance, Depression, Tendonitis
Adverse event resulted in: hospitalization
Suspect drug(s):
Aromasin (Exemestane)
Other drugs received by patient: Lopressor; Maxzide; Singulair; Welchol; Citracal + D; Ascorbic Acid; Glucosamine; Aspirin; Mavik
Adverse event in 53 year old female receiving Aromasin (Exemestane)
Reported by a consumer/non-health professional from United States on 2007-07-26
Patient: 53 year old female, weighing 46.3 kg (101.9 pounds)
Adverse reactions / side effects: Rheumatoid Arthritis, Arthropathy, Drug Interaction
Suspect drug(s):
Arimidex
Indication: Breast Cancer
Start date: 2006-10-01
Aromasin
Methotrexate
Other drugs received by patient: Celebrex
Adverse event in female receiving Aromasin (Exemestane)
Reported by a physician from Belgium on 2007-07-19
Patient: female
Adverse reactions / side effects: Neurosis
Suspect drug(s):
Aromasin (Exemestane)
Adverse event in female receiving Aromasin (Exemestane)
Reported by a physician from United States on 2007-07-19
Patient: female
Adverse reactions / side effects: Atrial Fibrillation
Suspect drug(s):
Aromasin
Dosage: freq:1 dose daily
Administration route: Oral
Indication: Breast Cancer
Start date: 2007-05-08
End date: 2007-06-25
Aromasin
Lupron
Indication: Breast Cancer
Adverse event in female receiving Aromasin (Exemestane)
Reported by a individual with unspecified qualification from United States on 2007-07-18
Patient: female, weighing 68.2 kg (150.0 pounds)
Adverse reactions / side effects: Confusional State, Hyperkalaemia, Diarrhoea, Oedema Peripheral, Haemorrhoids, Mental Status Changes, Hallucination
Adverse event resulted in: hospitalization
Suspect drug(s):
Aromasin (Exemestane)
Adverse event in female receiving Aromasin (Exemestane)
Reported by a physician from United States on 2007-07-13
Patient: female
Adverse reactions / side effects: Hepatotoxicity, Aspartate Aminotransferase Increased, Alanine Aminotransferase Increased, Eosinophilia
Suspect drug(s):
Aromasin (Exemestane)
Other drugs received by patient: Calcium Chloride; Ascorbic Acid; Vitamin CAP; Aspirin
Adverse event in female receiving Aromasin (Exemestane)
Reported by a physician from Japan on 2007-07-13
Patient: female
Adverse reactions / side effects: Hepatic Function Abnormal
Suspect drug(s):
Aromasin (Exemestane)
Adverse event in female receiving Aromasin (Exemestane)
Reported by a consumer/non-health professional from Germany on 2007-07-13
Patient: female
Adverse reactions / side effects: Optic Neuritis
Adverse event resulted in: hospitalization
Suspect drug(s):
Aromasin (Exemestane)
Adverse event in female receiving Aromasin (Exemestane)
Reported by a physician from Japan on 2007-07-05
Patient: female
Adverse reactions / side effects: Hepatic Function Abnormal
Suspect drug(s):
Aromasin (Exemestane)
Adverse event in female receiving Aromasin (Exemestane)
Reported by a physician from Italy on 2007-07-05
Patient: female
Adverse reactions / side effects: Atrial Fibrillation
Suspect drug(s):
Aromasin (Exemestane)
|
